CHENGDU,China,Dec. 27,2024--BGM Group Ltd. (Nasdaq: BGM) (the "Company" or "BGM"),a leading global pharmaceutical enterprise,today announced completion of the acquisition of the in
01-03
Introducing Hyaluronic Acid,Exosomes,and PDRN SEOUL,South Korea,Dec. 30,2024-- Maypharm Co.,Ltd.,a leading innovator in medical and dermo-cosmetic products,proudly introduces the global launch of Hyal
01-03
SUZHOU,China,Dec. 30,2024-- Hangzhou Sino-US Huadong Medicine Co.,Ltd. (hereinafter referred to as "Huadong Medicine"),a wholly-owned subsidiary of Huadong Medicine Co.,Ltd. (SZ.000963),and
01-03
BEIJING,Dec. 30,2024-- "On the new journey,major-country diplomacy with Chinese characteristics will enter a new stage where much more can be accomplished," stated the Central Conference on
01-03
TAIPEI,Dec. 30,2024-- As the calendar turns,ARTERY Technology extends warm New Year greetings! In 2024,leveraging professional expertise and technological breakthroughs,we made steady progress in a ra
01-03
Closing 2024 with close to 25% revenue growth,including a strong fourth quarter,Dataloy Systems continues to strengthen its position in maritime digitalisation.
01-03
SEOUL,South Korea,Dec. 31,2024-- CG MedTech (f/k/a Innosys,CEO Ju Mi Chung),a leading Korean orthopedic implant research and manufacturing company,partnered with CGBIO to host the International Spine
01-03
JIANGYIN,China,Dec. 31,2024-- SJ Semiconductor Corporation (hereinafter referred to as "SJSemi" or "the company") announced the efficient and successful closure of a new financing
01-03
SHANGHAI,Jan. 1,2025-- Boqii Holding Limited ("We," "Boqii" or the "Company") (NYSE American: BQ),a leading pet-focused platform in China,today announced its unaudited fi
01-03
SHENZHEN,China,Jan. 2,2025-- MicroAlgo Inc. (the "Company" or "MicroAlgo") (NASDAQ:MLGO),today announcedthe development of an innovative hybrid algorithm that combines the advantag
01-03
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map
